A lot of growing life sciences companies delay implementing an eQMS because they assume it will be expensive, painfully complex, and designed only for big pharma. Scilife is one of the few platforms that genuinely breaks that perception.
What impressed us is how accessible and scalable the system feels for smaller and mid-sized biotech teams that need structure and inspection readiness without a massive enterprise burden. The implementation is pragmatic, the user adoption is far easier than expected, and the platform avoids the heavy, overly engineered feel that many larger systems create.
In practice, we’ve found it gives companies a far more realistic route into digital quality management than platforms like Veeva, particularly for organisations still building operational maturity. Review collected by and hosted on G2.com.
Some very large enterprise companies may want deeper customisation in certain areas. But honestly, for growing biotech/medtech and medium sized pharma teams, the fact Scilife is less heavy and easier to implement than platforms like Veeva is part of the appeal. Review collected by and hosted on G2.com.
Hi Aleksandra,
I just wanted to say a huge thank you for taking the time to leave such a thoughtful review on G2. Reading feedback like yours truly means a lot to the whole team.
We're especially happy that you see Scilife as a practical, scalable solution for growing life sciences companies. That's exactly what we set out to build, and it's incredibly rewarding to hear it reflected in your experience.
Thank you as well for your continued trust and partnership. We're looking forward to continuing to grow together!
